Asthma Clinical Trial
Official title:
A Double Blind Randomised Placebo Controlled Pilot Study of a Dietary Soup Intervention During Pregnancy to Optimise Dietary Vitamin E Intake in Relation to Childhood Asthma.
| Verified date | January 2014 |
| Source | University of Aberdeen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United Kingdom: Research Ethics Committee |
| Study type | Interventional |
In the last forty years the prevalence of asthma has increased in westernised countries. We
have hypothesised that this increase may be a consequence of changing diet. Several birth
cohort studies have now reported an association between reduced maternal vitamin E intake
during pregnancy and childhood asthma.
However, it remains to be seen whether increasing maternal vitamin E intake during pregnancy
reduces the risk of childhood asthma. We are planning a large placebo controlled trial in
pregnant women, to investigate whether optimisation of dietary vitamin E intake to the
recommended 15mg/day reduces the likelihood of childhood asthma. We believe that a dietary
intervention using vitamin E in its natural form of food is more likely to be successful and
acceptable than a vitamin E supplement. We have previously demonstrated than pregnant women
can optimise their vitamin E intake using a personalised dietary plan with the help of a
dietitian however this intervention was complex and could not be translated into everyday
use. With commercial support we have developed a range of soups containing foods naturally
rich in vitamin E designed to optimise maternal vitamin E intake to 15mg/day. A range of
similar tasting and looking placebo soups has also been developed. In this study we will
pilot a randomised controlled trial of the active and placebo soups to ascertain whether
pregnant women are willing and able to optimise their vitamin E intake during pregnancy
using the soups in order to reduce the risk of their child developing asthma. optimising
maternal vitamin E intake during pregnancy.
| Status | Completed |
| Enrollment | 59 |
| Est. completion date | January 2014 |
| Est. primary completion date | June 2013 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 16 Years to 50 Years |
| Eligibility |
Inclusion Criteria: - 10-12 weeks pregnant. - Routine low risk antenatal care. - A personal or partner history of asthma at anytime. - Able and willing to give informed consent to participate - Able and willing to participate in the study procedures Exclusion Criteria: - Use of vitamin E supplements. - A history of diabetes, coagulopathies or use of anticoagulants, use of clopidogrel, cholestyramine, cyclosporin A, gemfibrozil, isoniazid, orlistat, anticonvulsants. - Any other significant disease or disorder which, in the opinion of the investigator, either puts the woman at risk because of participating in the study or may influence the results of the study, or the woman's ability to participate in the study. - Participating in another clinical study - Previous allocation of randomisation code in the study. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Aberdeen Maternity Hospital | Aberdeen |
| Lead Sponsor | Collaborator |
|---|---|
| University of Aberdeen |
United Kingdom,
Devereux G, Turner SW, Craig LC, McNeill G, Martindale S, Harbour PJ, Helms PJ, Seaton A. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med. 2006 Sep 1;174(5):499-507. Epub 2006 Jun 8. — View Citation
Litonjua AA, Rifas-Shiman SL, Ly NP, Tantisira KG, Rich-Edwards JW, Camargo CA Jr, Weiss ST, Gillman MW, Gold DR. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr. 2006 Oct;84(4):903-11. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Biomarker of dietary compliance | 1 year | No | |
| Primary | Participation of pregnant women in a randomised trial of enhanced and placebo soups from 12 weeks gestation until delivery. | 1 year | No | |
| Secondary | Dietary vitamin E intake during pregnancy. | 1 year | No | |
| Secondary | Lung function of new born infants. | 1 year | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|